Crsp stock forecast 2025.
May 19, 2023 · Cash and securities were $1.9 billion as of March 31, 2023 and net loss was only $53.1 million for Q1 2023, so there is no danger of dilution in the near future. Under the Vertex Joint Development ...
CRISPR Therapeutics Future Growth Future criteria checks 2/6 CRISPR Therapeutics is forecast to grow earnings and revenue by 46.4% and 48.2% per annum …May 2, 2022 · We asked three Motley Fool contributors to pick beaten-down stocks they think can deliver 5x gains by 2030. Here's why they chose CRISPR Therapeutics ( CRSP -0.74%), Ginkgo Bioworks Holdings ( DNA ... Stock Price Forecast. The 12 analysts offering 12-month price forecasts for Shell PLC have a median target of 75.10, with a high estimate of 88.00 and a low estimate of 66.00. The median estimate ...Let's take a closer look at Nio's growth over the years. In 2019, Nio produced 20,565 electric vehicles. It more than doubled its production to 43,728 units in 2020. Likewise, the company again ...
Oct 26, 2023 · Price Prediction forecast forCRISPR Therapeutics to October 27, and an in-depth analysis for the week of 22 October to 28 October. Monthly forecasts CRSP for 2023 with target levels, support & resistance insights to make informed investment decisions. Nov 1, 2023 · Forecast for December 2025. It is predicted that the price of one CRISPR Therapeutics share in will be in the range of $52.12 to $60.68. The width of this range will be $8.56 (14.10%). The average price is $54.03, which is $0.17 less than the average price of the previous month.
Stock Price Forecast The 19 analysts offering 12-month price forecasts for MercadoLibre Inc have a median target of 1,700.00, with a high estimate of 2,120.00 and a low estimate of 1,500.00.The global CRISPR gene editing market was valued at $846.2 million in 2019 and is expected to reach $10,825.1 million by 2030, registering a CAGR of 26.86% during the forecast.
View the latest CRISPR Therapeutics AG (CRSP) stock price, news, historical charts, analyst ratings and financial information from WSJ.CRISPR Therapeutics will start 2025 at $49.04, then soar to $49.76 within the first six months of the year and finish 2025 at $57.16. That means +48% from today. CRISPR Therapeutics Stock Forecast 2030-2034. In this period, the CRISPR Therapeutics price would rise from $82.55 to $103.44, which is +25%.See CRISPR Therapeutics AG (CRSP) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ... The average TDOC stock price target stood at $124.77 a share, resulting in a potential 64% upside based on the last closing price of $75.86 (as of 28 February). The highest 12-month Teladoc share price forecast was $215, while the lowest was set at $67. Right after the company announced its results for the fourth quarter of the 2021 fiscal …
The average CRISPR Therapeutics AG stock forecast 2024 represents a -25.46% decrease from the last price of $68.6500015258789. For CRISPR Therapeutics AG stock forecast for 2025, 12 predictions are offered for each month of 2025 with average CRISPR Therapeutics AG stock forecast of $49.41, a high forecast of $51.16, and a low forecast of $46.49.
Ford stock (F) has risen by more than 40 percent year-to-date, in part due to its strong EV potential. What's Ford's stock forecast for 2025? Growth stocks, including pure-play EV (electric ...
Apple Inc () Stock Market info Recommendations: Buy or sell Apple stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Apple share forecasts, stock quote and buy / sell signals below.According to present data Apple's AAPL shares and potentially its market environment have been in a bullish cycle in the last 12 …CRISPR Therapeutics AG analyst ratings, historical stock prices, earnings estimates & actuals. CRSP updated stock price target summary.See CRISPR Therapeutics AG (CRSP) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. It is projected to grow at a compounded annual growth rate of 8% to be valued at $14 billion by 2030. Under the terms of the deal, Vertex paid CRISPR $100 million up front for those rights and ...If we look at the company’s services, clients and according to stock market experts, 1st tdoc stock forecast 2025 can go up to 170.89 USD and 2nd tdoc stock price target is 192.75 USD in 2025, Teladoc Inc. has divided its services into 6 parts which include guidance and support, expert medical services, mental health services, platform and ...Target values for the price of one CRISPR Therapeutics share for Feb 2026. The weighted average target price per CRISPR Therapeutics share in Feb 2026 is: 39.08. In Feb, the Negative dynamics for Momo shares will prevail with possible monthly volatility of 15.704% volatility is expected. Pessimistic target level: 35.58.
Nov 28, 2023 · Target values for the price of one CRISPR Therapeutics share for Jan 2024. The weighted average target price per CRISPR Therapeutics share in Jan 2024 is: 63.59. In Jan, the Negative dynamics for Momo shares will prevail with possible monthly volatility of 15.790% volatility is expected. Pessimistic target level: 56.98. Price Prediction forecast forCRISPR Therapeutics to October 27, and an in-depth analysis for the week of 22 October to 28 October. Monthly forecasts CRSP for 2023 with target levels, support & resistance insights to make informed investment decisions.Find the latest Caribou Biosciences, Inc. (CRBU) stock quote, history, news and other vital information to help you with your stock trading and investing.The Veracyte stock forecast is 49.167390804547 USD for 2024 November 20, Wednesday; and 222.634 USD for 2028 November 20, Monday with technical analysis. Veracyte (VCYT) stock price prediction is 49.167390804547 USD.Dec 1, 2023 · According to 16 stock analysts, the average 12-month stock price forecast for CRSP stock stock is $69.88, which predicts an increase of 1.79%. The lowest target is $42 and the highest is $110. On average, analysts rate CRSP stock stock as a buy. Analyst Consensus: Buy Analyst Ratings Find the latest Caribou Biosciences, Inc. (CRBU) stock quote, history, news and other vital information to help you with your stock trading and investing.
Lucid Group Inc () Stock Market info Recommendations: Buy or sell Lucid Group stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Lucid Group share forecasts, stock quote and buy / sell signals below.According to present data Lucid Group's LCID shares and potentially its market environment have been in bearish …
Current. -$0.94. 1 Month Ago. -$1.09. 3 Months Ago. -$0.99. CRISPR Therapeutics AG analyst estimates, including CRSP earnings per share estimates and analyst recommendations.Apr 13, 2022 · Among the leaders in the nascent CRISPR space are biotech stocks like CRISPR Therapeutics, (CRSP 2.88%) Editas Medicine, and Intellia Therapeutics. These companies have pipelines that are jam ... CRISPR Therapeutics will start 2025 at $49.04, then soar to $49.76 within the first six months of the year and finish 2025 at $57.16. That means +48% from today. CRISPR Therapeutics Stock Forecast 2030-2034. In this period, the CRISPR Therapeutics price would rise from $82.55 to $103.44, which is +25%.MERCERWISE 2025 TARGET DATE C- Performance charts including intraday, historical charts and prices and keydata. Indices Commodities Currencies StocksTarget values for the price of one CRISPR Therapeutics share for Nov 2026. The weighted average target price per CRISPR Therapeutics share in Nov 2026 is: 45.09. In Nov, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 10.682% volatility is expected. Pessimistic target level: 43.43.Meta Platforms Inc. () Stock Market info Recommendations: Buy or sell Meta Platforms stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Meta Platforms share forecasts, stock quote and buy / sell signals below.According to present data Meta Platforms's META shares and potentially its market environment have …December 2025. Festive spending and end-of-year portfolio adjustments might lead VOO to end on a high note. Predicted Price Range: $450-$470. In the realm of investments, understanding potential trajectories like this can be empowering. Yet, always remember that these are speculative figures.Price Prediction CRISPR Therapeutics price predictions from 2023 to 2027. Gain insights into monthly forecasts, trends, and analyses to make informed investment decisions.
CPRX Stock 12 Months Forecast. $23.30. (81.32% Upside) Based on 5 Wall Street analysts offering 12 month price targets for Catalyst Pharma in the last 3 months. The average price target is $23.30 with a high forecast of $27.00 and a low forecast of $15.50. The average price target represents a 81.32% change from the last price of $12.85.
NEW YORK, Jan. 14, 2020 /PRNewswire/ --The Global Sports Analytics Market size is expected to reach $4.3 billion by 2025, rising at a market growt... NEW YORK, Jan. 14, 2020 /PRNewswire/ -- The Global Sports Analytics Market size is expecte...
The average CRISPR Therapeutics AG stock forecast 2024 represents a -25.46% decrease from the last price of $68.6500015258789. For CRISPR Therapeutics AG stock forecast for 2025, 12 predictions are offered for each month of 2025 with average CRISPR Therapeutics AG stock forecast of $49.41, a high forecast of $51.16, and a low forecast of $46.49. CRISPR Therapeutics Stock Up 14.6 %. NASDAQ:CRSP opened at $67.89 on Friday. The company’s 50 day moving average price is $46.64 and its 200-day moving average price is $53.09. CRISPR Therapeutics has a 52 week low of $37.55 and a 52 week high of $72.00. The stock has a market cap of $5.39 billion, a price-to-earnings ratio of -15.19 and a ...Oct 26, 2023 · Price Prediction forecast forCRISPR Therapeutics to October 27, and an in-depth analysis for the week of 22 October to 28 October. Monthly forecasts CRSP for 2023 with target levels, support & resistance insights to make informed investment decisions. CRISPR Therapeutics last issued its quarterly earnings data on November 6th, 2023. The reported ($1.41) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($2.04) by $0.63. CRISPR Therapeutics has generated ($4.47) earnings per share over the last year ( ($4.47) diluted earnings per share).Oct 15, 2020 · CRISPR Therapeutics AG (CRSP) stock price prediction is 130.64207402132 USD. The CRISPR Therapeutics AG stock forecast is 130.64207402132 USD for 2024 November 24, Sunday; and 586.145 USD for 2028 November 24, Friday with technical analysis. Lastly, social media stock Meta Platforms ( META -1.04%), the company formerly known as Facebook, should find itself as one of the 10 largest stocks in 2030. You'll note that current top-10 stocks ...Find real-time ABNB - Airbnb Inc stock quotes, company profile, news and forecasts from CNN Business.Discover historical prices for CRSP stock on Yahoo Finance. View daily, weekly or monthly format back to when CRISPR Therapeutics AG stock was issued.Find real-time NCLH - Norwegian Cruise Line Holdings Ltd stock quotes, company profile, news and forecasts from CNN Business.Wall Street Stock Market & Finance report, prediction for the future: You'll find the Editas Medicine share forecasts, stock quote and buy / sell signals below. According to present data Editas Medicine's EDIT shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists).
Find the latest CRISPR Therapeutics AG CRSP analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports. Date Range. investment rating. The current CRISPR Therapeutics AG [ CRSP] share price is $66.73. The Score for CRSP is 52, which is 4% above its historic median score of 50, and infers lower risk than normal. CRSP is currently trading in the 50-60% percentile range relative to …AT&T Stock Forecast 12-07-2023. Forecast target price for 12-07-2023: $ 16.48. Negative dynamics for AT&T shares will prevail with possible volatility of 1.632%. Pessimistic target level: 16.40. Optimistic target level: 16.67.AA Stock 12 Months Forecast. $28.05. (1.12% Upside) Based on 10 Wall Street analysts offering 12 month price targets for Alcoa in the last 3 months. The average price target is $28.05 with a high forecast of $41.00 and a low forecast of $14.00. The average price target represents a 1.12% change from the last price of $27.74.Instagram:https://instagram. o divihow to make a stock portfoliodental plans arizonaviona magnetics 8 thg 8, 2022 ... BVPS Estimate. 2022, -8.64, 22.53. 2023, -7.5, 15.03. 2024, -3.84, 11.19. 2025 ... Might the recent decline in CRSP's share price have an impact ...Price target in 14 days: 89.877 USD. The best long-term & short-term CRISPR Therapeutics AG share price prognosis for 2023, 2024, 2025, 2026, 2027, 2028 with daily CRSP … nuvbxcomputers trading Casper Sleep Inc. (NYSE:CSPR) announced its quarterly earnings results on Monday, November, 15th. The company reported ($0.61) earnings per share for the quarter, missing the consensus estimate of ($0.43) by $0.18. The company had revenue of $156.50 million for the quarter, compared to analyst estimates of $156.15 million. 3d printers under 200 CRSP stock soared in 2021 along with many biotech stocks. But there’s been a sharp pullback since then. ... In fact, Pfizer is forecasting that the company’s pipeline will growt by $10 billion ...Teladoc Health Stock Forecast 12-04-2023. Forecast target price for 12-04-2023: $ 18.40. Positive dynamics for Teladoc Health shares will prevail with possible volatility of 2.308%. Pessimistic target level: 18.09. Optimistic target level: 18.52.The average twelve-month price prediction for CRISPR Therapeutics is $69.88 with a high price target of $110.00 and a low price target of $42.00. Learn more on CRSP's analyst rating history. Do Wall Street analysts like CRISPR Therapeutics more than its competitors?